Sequential BCR::ABL1 evaluation during dose de-escalation in peripheral blood is more predictive of TFR success than single assessment at dose de-escalation in either peripheral blood or bone marrow

Research output: Contribution to journal › Letter › Contributed › peer-review

Contributors

S D Patterson - , University of Glasgow (Author)
A Gottschalk - , Institute for Medical Informatics and Biometry (Author)
C Hayden - , North West London Pathology (Author)
R Young - , University of Glasgow (Author)
A Hair - , University of Glasgow (Author)
H G Jørgensen - , University of Glasgow (Author)
H W Wheadon - , University of Glasgow (Author)
J F Apperley - , University College London (Author)
I Glauche - , Institute for Medical Informatics and Biometry (Author)
R E Clark - , University of Liverpool (UOL) (Author)
M Copland - , University of Glasgow (Author)
I Roeder - , Institute for Medical Informatics and Biometry, National Center for Tumor Diseases Dresden (Author)